October 30, 2024
TOPLINE: Combining thoracic radiotherapy with first-line EGFR tyrosine kinase inhibitor (TKI) therapy improves progression-free survival by 6.5 months and overall survival by more than 8 months […]
October 30, 2024
TOPLINE: Hearing loss is associated with a 26% higher risk for Parkinson’s disease (PD), although hearing aids helped mitigate the risk, a new study shows. METHODOLOGY: […]
October 30, 2024
TOPLINE: Having a diagnosis of dementia is associated with an increase in emergency department (ED) visits in the United States, highlighting a potential health crisis and […]
October 29, 2024
TOPLINE: People diagnosed with type 2 diabetes (T2D) at age < 40 years had a high risk for incident diabetes-related complications, excess age-standardised mortality, and poorer […]
October 29, 2024
TOPLINE: Opioid use has multiple negative effects on the endocrine system and can lead to reproductive, bone, and adrenal hormone health complications, reported a scientific statement. […]
October 28, 2024
TOPLINE: Children of mothers who had obesity or eating disorders before or during pregnancy may face higher risks for neurodevelopmental and psychiatric disorders. METHODOLOGY: Researchers conducted […]
October 28, 2024
TOPLINE: Adding pembrolizumab to adjuvant chemotherapy in the first-line setting improved disease-free survival (DFS) in patients with high-risk endometrial cancer who have mismatch repair–deficient (dMMR) tumors, […]
October 28, 2024
TOPLINE: Allogeneic bone marrow–derived mesenchymal stromal cells (BM-MSCs) are safe but do not show efficacy in treating intervertebral disc degeneration (IDD) in patients with chronic low […]
October 28, 2024
TOPLINE: Atezolizumab combined with targeted therapy improved median overall survival to 19 months in patients with anaplastic thyroid carcinoma (ATC). The longest survival was observed in […]